News

June 25, 2018

FDA Approves Marketing Of Plant-Derived Marijuana Medicine

Regulators at the US Food and Drug Administration today granted market approval for Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.
June 22, 2018

Weekly Legislative Roundup 6/22/18

Welcome to the latest edition of NORML's Weekly Legislative Roundup!
June 22, 2018

Kentucky NORML: Cannabis Access Associated with Reduced Rates of Opioid Use and Abuse

KY NORML is passionate about education. And with the opioid epidemic consuming our state, we feel that it is our duty to share valuable information regarding the relationship between cannabis and opioids.
June 20, 2018

NORML Releases Comprehensive Report Summarizing Local Decriminalization Laws

Even though recreational marijuana remains criminalized in a majority of US states, more and more municipalities are moving ahead with local laws decriminalizing the possession of cannabis within city limits. For the first time, NORML has released a comprehensive breakdown of these citywide and countywide decriminalization policies.